P. Ancel, F. Goffinet, . Epipage-2-writing, . Group, P. Kuhn et al., Survival and morbidity of preterm children born at 22 through 34 weeks' gestation in France in 2011: results of the EPIPAGE-2 cohort study, JAMA Pediatr, vol.169, pp.230-238, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01258705

B. Larroque, P. Ancel, S. Marret, L. Marchand, M. André et al., Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study, Lancet, vol.371, pp.813-833, 2008.

E. Sellier, M. J. Platt, G. L. Andersen, I. Krägeloh-mann, D. Cruz et al., Decreasing prevalence in cerebral palsy: a multi-site European populationbased study, Dev Med Child Neurol, vol.58, pp.85-92, 1980.
URL : https://hal.archives-ouvertes.fr/hal-02007920

K. Himmelmann and P. Uvebrant, The panorama of cerebral palsy in Sweden. XI. Changing patterns in the birth-year period 2003-2006, Acta Paediatr, vol.103, pp.618-642, 2014.

L. W. Doyle, C. A. Crowther, P. Middleton, S. Marret, and D. Rouse, Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus, Cochrane Database Syst Rev, issue.1, p.4661, 2009.

S. Marret, P. Gressens, J. F. Gadisseux, and P. Evrard, Prevention by magnesium of excitotoxic neuronal death in the developing brain: an animal model for clinical intervention studies, Dev Med Child Neurol, vol.37, pp.473-84, 1995.

H. T. Wolf, H. K. Hegaard, G. Greisen, L. Huusom, and M. Hedegaard, Treatment with magnesium sulphate in pre-term birth: a systematic review and metaanalysis of observational studies, J Obstet Gynaecol, vol.32, pp.135-175, 2012.

R. Mittendorf, J. Dambrosia, P. G. Pryde, K. Lee, J. G. Gianopoulos et al., Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants, Am J Obstet Gynecol, vol.186, pp.1111-1119, 2002.

D. Altman, G. Carroli, L. Duley, B. Farrell, J. Moodley et al., Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial, Lancet, vol.359, pp.1877-90, 2002.

C. A. Crowther, J. E. Hiller, L. W. Doyle, and R. R. Haslam, Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial, JAMA, vol.290, pp.2669-76, 2003.

D. J. Rouse, D. G. Hirtz, E. Thom, M. W. Varner, C. Y. Spong et al., A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy, N Engl J Med, vol.359, pp.895-905, 2008.

S. Marret, L. Marpeau, V. Zupan-simunek, D. Eurin, C. Lévêque et al., Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial, BJOG, vol.114, pp.310-318, 2007.

S. Marret, L. Marpeau, and J. Bénichou, Benefit of magnesium sulfate given before very preterm birth to protect infant brain, Pediatrics, vol.121, pp.225-231, 2008.

L. W. Doyle, C. A. Crowther, P. Middleton, and S. Marret, Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus, Cochrane Database Syst Rev, issue.3, p.4661, 2007.

M. M. Costantine and S. J. Weiner, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis, Obstet Gynecol, vol.114, pp.354-64, 2009.

A. Conde-agudelo and R. Romero, Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis, Am J Obstet Gynecol, vol.200, pp.595-609, 2009.

X. Zeng, Y. Xue, Q. Tian, R. Sun, and A. R. , Effects and Safety of Magnesium Sulfate on Neuroprotection: A Meta-analysis Based on PRISMA Guidelines, Medicine, vol.95, p.2451, 2016.

, American College of Obstetricians and Gynecologists Committee on Obstetric Practice, Society for Maternal-Fetal Medicine. Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection, Obstet Gynecol, vol.115, pp.669-71, 2010.

, American College of Obstetricians and Gynecologists, Society for MaternalFetal Medicine. ACOG Obstetric Care Consensus No. 3: Periviable Birth, Obstet Gynecol, vol.126, pp.82-94, 2015.

, Antenatal magnesium sulphate prior to preterm birth for neuroprotection of the fetus, infant and child: National clinical practice guidelines, 2010.

L. Magee, D. Sawchuck, A. Synnes, and P. Von-dadelszen, SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection, J Obstet Gynaecol Can, vol.33, pp.516-545, 2011.

, National Collaborating Centre for Women's and Children's Health (UK)

, Preterm Labour and Birth, 2015.

. Belgian-helath-care-knowledge and . Centre, Prevention of preterm birth in women at risk: selected topics, 2014.

, Antenatal magnesium sulphate for fetal neuroprotection, 2013.

, Antenatal magnesium individual participant data international collaboration: assessing the benefits for babies using the best level of evidence (AMICABLE), Syst Rev, vol.1, p.21, 2012.

C. A. Crowther, P. F. Middleton, D. Wilkinson, P. Ashwood, R. Haslam et al., Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)-study protocol, BMC Pregnancy Childbirth, vol.13, p.91, 2013.

L. L. Ow, A. Kennedy, E. A. Mccarthy, and S. P. Walker, Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit, Aust N Z J Obstet Gynaecol, vol.52, pp.356-60, 2012.

K. J. Gibbins, K. R. Browning, V. V. Lopes, B. L. Anderson, and D. J. Rouse, Evaluation of the clinical use of magnesium sulfate for cerebral palsy prevention, Obstet Gynecol, vol.121, pp.235-275, 2013.

Y. H. Tan and K. M. Groom, A prospective audit of the adherence to a new magnesium sulphate guideline for the neuroprotection of infants born less than 30 weeks' gestation, Aust N Z J Obstet Gynaecol, vol.55, pp.90-93, 2015.

P. Bouet, S. Brun, H. Madar, A. Baisson, V. Courtay et al., Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infants, Sci Rep, vol.5, p.14732, 2015.

, magnesium sulfate before anticipated preterm birth for neuroprotection, Patient safety checklist, vol.120, issue.7, pp.432-435, 2012.